Biofrontera (BFRI) Change in Acquisitions & Divestments (2023 - 2024)

Biofrontera (BFRI) recorded quarterly Change in Acquisitions & Divestments of $57000.0 in Q1 2024, up 42.5% quarter-over-quarter from $40000.0 in Q4 2023.

Biofrontera (BFRI) Change in Acquisitions & Divestments (2023 - 2024) Analysis & Trends

Biofrontera's Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $57000.0 for Q1 2024.

  • In Q1 2024, Change in Acquisitions & Divestments changed N/A year-over-year to $57000.0; the TTM figure through Dec 2024 stood at $57000.0 (changed N/A YoY), while the FY2024 annual figure was $57000.0, down 90.5% from the prior year.
  • Change in Acquisitions & Divestments was $57000.0 for Q1 2024 at Biofrontera, up from $40000.0 in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $360000.0 in Q3 2023 to a low of $40000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn
10 Biofrontera 8.97 Mn 2.56 Mn 14.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2024 57,000.00
Mar 31, 2024 57,000.00
Dec 31, 2023 40,000.00
Dec 31, 2023 40,000.00
Sep 30, 2023 360,000.00
Sep 30, 2023 360,000.00